Category: Vaccine
Preprint: Vaccine effectiveness for the third dose in negative since December 2021
“There is no discernable vaccine effectiveness among ≥18 years of age, vaccinated third dose population since the beginning of the Omicron variant surge.” More...
Preprint: SARS-CoV-2 infection offered a high level of sustained protection against reinfection
“SARS-CoV-2 infection offered a high level of sustained protection against reinfection, comparable with that offered by vaccines..” More...
France: Deaths up 12% in one week as BA.5 increases its share
All the Covid indicators in France are currently heading in the wrong direction as BA.5 continues to increase its share of sequences. More...
Canada: “We will never be fully vaccinated against COVID-19”
Canadians will be required to get a booster shot every nine months for the foreseeable future, says Canadian Health Minister Jean-Yves Duclos. More...
Jenny Harris: Quite likely BA.5 hospitalizations will exceed those of BA.2
Dr Jenny Harris, of the UKHSA, has said in an interview today that it is quite likely that BA.5 hospitalizations will “peak over” those of the Omicron BA.2 wave, meaning that Britain could see the highest hospitalization figures for eighteen months. More...
Covid-19: Where’s the herd immunity?
“Contrary to the myth that we are sliding into a comfortable evolutionary relationship with a common-cold-like, friendly virus, this is more like being trapped on a rollercoaster in a horror film.” More...
WHO: BA.5 now dominant globally
As of epidemiological week 24, BA.5 represents 43% of global sequences at Gisaid, BA.2 represents 25%, BA.4 represents 12%, and BA.2.12.1 represents 11%. More...
Anthony Fauci Paxlovid rebound
Anthony Fauci has been talking about his recent Covid infection, and seeing the infection rebound after a course of Paxlovid. More...
Preprint: BA.2.12.1, BA.4, and BA.5 substantially escape neutralizing antibodies
These data show that the BA.2.12.1, BA.4, and BA.5 subvariants substantially escape neutralizing antibodies induced by both vaccination and infection. More...
France: BA.5 at 41% of sequences in week 24, 2022
“Progressive replacement of BA.2 by BA.5 with a strong increase in detection (41%), increased presence of the mutation at position L452 in screening (64% in week 24 vs 47% in week 23), linked to the increase of certain Omicron sub-lineages including BA.4 and BA.5.” More...